Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-08-30

AUTHORS

Laura D. Bilek, Nancy L. Waltman, Joan M. Lappe, Kevin A. Kupzyk, Lynn R. Mack, Diane M. Cullen, Kris Berg, Meghan Langel, Melissa Meisinger, Ashlee Portelli-Trinidad, Molly Lang

ABSTRACT

BackgroundIn the United States, over 34 million American post-menopausal women have low bone mass (osteopenia) which increases their risk of osteoporosis and fractures. Calcium, vitamin D and exercise are recommended for prevention of osteoporosis, and bisphosphonates (BPs) are prescribed in women with osteoporosis. BPs may also be prescribed for women with low bone mass, but are more controversial due to the potential for adverse effects with long-term use. A bone loading exercise program (high-impact weight bearing and resistance training) promotes bone strength by preserving bone mineral density (BMD), improving bone structure, and by promoting bone formation at sites of mechanical stress.Methods/DesignThe sample for this study will be 309 women with low bone mass who are within 5 years post-menopause. Subjects are stratified by exercise history (≥2 high intensity exercise sessions per week; < 2 sessions per week) and randomized to a control or one of two treatment groups: 1) calcium + vitamin D (CaD) alone (Control); 2) a BP plus CaD (Risedronate); or 3) a bone loading exercise program plus CaD (Exercise). After 12 months of treatment, changes in bone structure, BMD, and bone turnover will be compared in the 3 groups. Primary outcomes for the study are bone structure measures (Bone Strength Index [BSI] at the tibia and Hip Structural Analysis [HSA] scores). Secondary outcomes are BMD at the hip and spine and serum biomarkers of bone formation (alkaline phosphase, AlkphaseB) and resorption (Serum N-terminal telopeptide, NTx). Our central hypothesis is that improvements in bone strength will be greater in subjects randomized to the Exercise group compared to subjects in either Control or Risedronate groups.DiscussionOur research aims to decrease the risk of osteoporotic fractures by improving bone strength in women with low bone mass (pre-osteoporotic) during their first 5 years’ post-menopause, a time of rapid and significant bone loss. Results of this study could be used in developing a clinical management pathway for women with low bone mass at their peak period of bone loss that would involve lifestyle modifications such as exercises prior to medications such as BPs.Trial registrationClinicaltrials.gov NCT02186600. Initial registration: 7/7/2014. More... »

PAGES

59

References to SciGraph publications

  • 2012-12-04. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study in OSTEOPOROSIS INTERNATIONAL
  • 2009-10-03. The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial in OSTEOPOROSIS INTERNATIONAL
  • 2014-08-15. Clinician’s Guide to Prevention and Treatment of Osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2004-03. Exercise motivation and adherence in cancer survivors after participation in a randomized controlled trial: An attribution theory perspective in INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE
  • 2013-01-10. The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture in OSTEOPOROSIS INTERNATIONAL
  • 2012-11-13. A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data in CALCIFIED TISSUE INTERNATIONAL
  • 2007-06. Effects of microarchitecture on bone strength in CURRENT OSTEOPOROSIS REPORTS
  • 2013-07-02. Implications of local osteoporosis on the efficacy of anti-resorptive drug treatment: a 3-year follow-up finite element study in risedronate-treated women in OSTEOPOROSIS INTERNATIONAL
  • 2015-03-22. Adjusting Fracture Probability by Trabecular Bone Score in CALCIFIED TISSUE INTERNATIONAL
  • 2002-08-02. Bone Turnover Markers: Their Place in the Investigation of Osteoporosis in OSTEOPOROSIS
  • 2013-08-04. Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis in CALCIFIED TISSUE INTERNATIONAL
  • 2013-07-20. Hip structural analysis: a comparison of DXA with CT in postmenopausal Japanese women in SPRINGERPLUS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12905-016-0339-x

    DOI

    http://dx.doi.org/10.1186/s12905-016-0339-x

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1015577465

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/27576310


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Density Conservation Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Exercise", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis, Postmenopausal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporotic Fractures", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Postmenopause", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Randomized Controlled Trials as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Research Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Risedronic Acid", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.429696.6", 
              "name": [
                "College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bilek", 
            "givenName": "Laura D.", 
            "id": "sg:person.0660737247.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660737247.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Nursing, University of Nebraska Medical Center, 1230 O Street, Suite 131, 68588-0220, Lincoln, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.266813.8", 
              "name": [
                "College of Nursing, University of Nebraska Medical Center, 1230 O Street, Suite 131, 68588-0220, Lincoln, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Waltman", 
            "givenName": "Nancy L.", 
            "id": "sg:person.0765272574.62", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765272574.62"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Creighton Osteoporosis Research Center, 601 North 30th, 68131, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Creighton Osteoporosis Research Center, 601 North 30th, 68131, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lappe", 
            "givenName": "Joan M.", 
            "id": "sg:person.0714345342.23", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714345342.23"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Nursing Science, University of Nebraska Medical Center, 4101 Dewey Avenue, 68198-5330, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.266813.8", 
              "name": [
                "Center for Nursing Science, University of Nebraska Medical Center, 4101 Dewey Avenue, 68198-5330, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kupzyk", 
            "givenName": "Kevin A.", 
            "id": "sg:person.01210654346.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210654346.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Diabetes, Endocrinology, & Metabolism, Nebraska Medicine, 68198-4130, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.429696.6", 
              "name": [
                "Diabetes, Endocrinology, & Metabolism, Nebraska Medicine, 68198-4130, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mack", 
            "givenName": "Lynn R.", 
            "id": "sg:person.012673232265.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012673232265.95"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Biomedical Science, Creighton University, 68102, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.254748.8", 
              "name": [
                "Biomedical Science, Creighton University, 68102, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cullen", 
            "givenName": "Diane M.", 
            "id": "sg:person.0741432654.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741432654.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "School of HPER, University of Nebraska at Omaha, 68162-0216, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.266815.e", 
              "name": [
                "School of HPER, University of Nebraska at Omaha, 68162-0216, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Berg", 
            "givenName": "Kris", 
            "id": "sg:person.01332176174.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332176174.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Heartland Osteoporosis Research Study, College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.429696.6", 
              "name": [
                "Heartland Osteoporosis Research Study, College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Langel", 
            "givenName": "Meghan", 
            "id": "sg:person.015063553665.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015063553665.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Heartland Osteoporosis Research Study, College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.429696.6", 
              "name": [
                "Heartland Osteoporosis Research Study, College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Meisinger", 
            "givenName": "Melissa", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Heartland Osteoporosis Research Study, College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.429696.6", 
              "name": [
                "Heartland Osteoporosis Research Study, College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Portelli-Trinidad", 
            "givenName": "Ashlee", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA", 
              "id": "http://www.grid.ac/institutes/grid.429696.6", 
              "name": [
                "College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lang", 
            "givenName": "Molly", 
            "id": "sg:person.07753443465.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07753443465.98"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00198-009-1083-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047106998", 
              "https://doi.org/10.1007/s00198-009-1083-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-012-2224-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026832189", 
              "https://doi.org/10.1007/s00198-012-2224-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00223-013-9763-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007894857", 
              "https://doi.org/10.1007/s00223-013-9763-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1385/1-59259-278-3:185", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1088540921", 
              "https://doi.org/10.1385/1-59259-278-3:185"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-012-2240-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038429533", 
              "https://doi.org/10.1007/s00198-012-2240-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1207/s15327558ijbm1101_2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064221287", 
              "https://doi.org/10.1207/s15327558ijbm1101_2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/2193-1801-2-331", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013150939", 
              "https://doi.org/10.1186/2193-1801-2-331"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-014-2794-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038754393", 
              "https://doi.org/10.1007/s00198-014-2794-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00223-015-9980-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020842897", 
              "https://doi.org/10.1007/s00223-015-9980-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11914-007-0003-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005231316", 
              "https://doi.org/10.1007/s11914-007-0003-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-013-2424-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036817206", 
              "https://doi.org/10.1007/s00198-013-2424-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00223-012-9668-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023163828", 
              "https://doi.org/10.1007/s00223-012-9668-4"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2016-08-30", 
        "datePublishedReg": "2016-08-30", 
        "description": "BackgroundIn the United States, over 34 million American post-menopausal women have low bone mass (osteopenia) which increases their risk of osteoporosis and fractures. Calcium, vitamin D and exercise are recommended for prevention of osteoporosis, and bisphosphonates (BPs) are prescribed in women with osteoporosis. BPs may also be prescribed for women with low bone mass, but are more controversial due to the potential for adverse effects with long-term use. A bone loading exercise program (high-impact weight bearing and resistance training) promotes bone strength by preserving bone mineral density (BMD), improving bone structure, and by promoting bone formation at sites of mechanical stress.Methods/DesignThe sample for this study will be 309 women with low bone mass who are within 5\u00a0years post-menopause. Subjects are stratified by exercise history (\u22652 high intensity exercise sessions per week; < 2 sessions per week) and randomized to a control or one of two treatment groups: 1) calcium\u2009+\u2009vitamin D (CaD) alone (Control); 2) a BP plus CaD (Risedronate); or 3) a bone loading exercise program plus CaD (Exercise). After 12\u00a0months of treatment, changes in bone structure, BMD, and bone turnover will be compared in the 3 groups. Primary outcomes for the study are bone structure measures (Bone Strength Index [BSI] at the tibia and Hip Structural Analysis [HSA] scores). Secondary outcomes are BMD at the hip and spine and serum biomarkers of bone formation (alkaline phosphase, AlkphaseB) and resorption (Serum N-terminal telopeptide, NTx). Our central hypothesis is that improvements in bone strength will be greater in subjects randomized to the Exercise group compared to subjects in either Control or Risedronate groups.DiscussionOur research aims to decrease the risk of osteoporotic fractures by improving bone strength in women with low bone mass (pre-osteoporotic) during their first 5\u00a0years\u2019 post-menopause, a time of rapid and significant bone loss. Results of this study could be used in developing a clinical management pathway for women with low bone mass at their peak period of bone loss that would involve lifestyle modifications such as exercises prior to medications such as BPs.Trial registrationClinicaltrials.gov NCT02186600. Initial registration: 7/7/2014.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s12905-016-0339-x", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.3806235", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1028438", 
            "issn": [
              "1472-6874"
            ], 
            "name": "BMC Women's Health", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "16"
          }
        ], 
        "keywords": [
          "low bone mass", 
          "bone mineral density", 
          "bone mass", 
          "bone loss", 
          "bone strength", 
          "exercise program", 
          "vitamin D", 
          "bone-loading exercises", 
          "osteopenic postmenopausal women", 
          "bone formation", 
          "months of treatment", 
          "risk of osteoporosis", 
          "prevention of osteoporosis", 
          "post-menopausal women", 
          "significant bone loss", 
          "clinical management pathway", 
          "bone structure", 
          "long-term use", 
          "risedronate group", 
          "lifestyle modification", 
          "Secondary outcomes", 
          "exercise group", 
          "postmenopausal women", 
          "primary outcome", 
          "osteoporotic fractures", 
          "bone turnover", 
          "serum biomarkers", 
          "mineral density", 
          "treatment groups", 
          "management pathway", 
          "exercise history", 
          "bisphosphonates", 
          "osteoporosis", 
          "adverse effects", 
          "women", 
          "exercise", 
          "subjects", 
          "outcomes", 
          "risk", 
          "group", 
          "calcium", 
          "fractures", 
          "medications", 
          "risedronate", 
          "years", 
          "hip", 
          "resorption", 
          "trials", 
          "biomarkers", 
          "prevention", 
          "months", 
          "spine", 
          "study", 
          "BackgroundIn", 
          "United States", 
          "treatment", 
          "control", 
          "loss", 
          "mass", 
          "CAD", 
          "pathway", 
          "program", 
          "period", 
          "structure measures", 
          "history", 
          "protocol", 
          "measures", 
          "central hypothesis", 
          "effect", 
          "turnover", 
          "improvement", 
          "hypothesis", 
          "changes", 
          "mechanical stress", 
          "use", 
          "stress", 
          "samples", 
          "sites", 
          "time", 
          "potential", 
          "results", 
          "formation", 
          "modification", 
          "peak period", 
          "research", 
          "strength", 
          "state", 
          "density", 
          "structure"
        ], 
        "name": "Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women", 
        "pagination": "59", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1015577465"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12905-016-0339-x"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "27576310"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12905-016-0339-x", 
          "https://app.dimensions.ai/details/publication/pub.1015577465"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T21:00", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_711.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s12905-016-0339-x"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12905-016-0339-x'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12905-016-0339-x'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12905-016-0339-x'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12905-016-0339-x'


     

    This table displays all metadata directly associated to this object as RDF triples.

    345 TRIPLES      21 PREDICATES      141 URIs      121 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12905-016-0339-x schema:about N248e4c11d6554fa49236aeefc4fe1e84
    2 N2bbd40b607904e0497c1a735bb38cd16
    3 N3875a5f56e5b428cabab07d100690e53
    4 N3977192510c044b1ae449bedc372e0ab
    5 N461720e267244889868f2074bf5b13e9
    6 N494f85b609334c88be43ae538f242f39
    7 N56cda81e8b3b42d2ac32ff072283b944
    8 N5a4fec79c38140a399eb67923fde508d
    9 N5d6ab7748f4f46f5b6e76105fced6b06
    10 N7d2bad81cd7c4c9e9419435f599a413d
    11 N82a7637152974d4ea9e6c756ee24de05
    12 Nadf46bc09c1a49ae8771d6e1d4a2cabf
    13 Nb5bc14b47e28450b95d8f338ef7b121e
    14 Nd2508b96deea418a94ee930b1e4ffec0
    15 Nff9ae797fa604c169e59904d506c7bd0
    16 anzsrc-for:11
    17 anzsrc-for:1103
    18 schema:author N8fca0d87e34b4c819f42b598bf3f3c48
    19 schema:citation sg:pub.10.1007/s00198-009-1083-y
    20 sg:pub.10.1007/s00198-012-2224-2
    21 sg:pub.10.1007/s00198-012-2240-2
    22 sg:pub.10.1007/s00198-013-2424-4
    23 sg:pub.10.1007/s00198-014-2794-2
    24 sg:pub.10.1007/s00223-012-9668-4
    25 sg:pub.10.1007/s00223-013-9763-1
    26 sg:pub.10.1007/s00223-015-9980-x
    27 sg:pub.10.1007/s11914-007-0003-3
    28 sg:pub.10.1186/2193-1801-2-331
    29 sg:pub.10.1207/s15327558ijbm1101_2
    30 sg:pub.10.1385/1-59259-278-3:185
    31 schema:datePublished 2016-08-30
    32 schema:datePublishedReg 2016-08-30
    33 schema:description BackgroundIn the United States, over 34 million American post-menopausal women have low bone mass (osteopenia) which increases their risk of osteoporosis and fractures. Calcium, vitamin D and exercise are recommended for prevention of osteoporosis, and bisphosphonates (BPs) are prescribed in women with osteoporosis. BPs may also be prescribed for women with low bone mass, but are more controversial due to the potential for adverse effects with long-term use. A bone loading exercise program (high-impact weight bearing and resistance training) promotes bone strength by preserving bone mineral density (BMD), improving bone structure, and by promoting bone formation at sites of mechanical stress.Methods/DesignThe sample for this study will be 309 women with low bone mass who are within 5 years post-menopause. Subjects are stratified by exercise history (≥2 high intensity exercise sessions per week; < 2 sessions per week) and randomized to a control or one of two treatment groups: 1) calcium + vitamin D (CaD) alone (Control); 2) a BP plus CaD (Risedronate); or 3) a bone loading exercise program plus CaD (Exercise). After 12 months of treatment, changes in bone structure, BMD, and bone turnover will be compared in the 3 groups. Primary outcomes for the study are bone structure measures (Bone Strength Index [BSI] at the tibia and Hip Structural Analysis [HSA] scores). Secondary outcomes are BMD at the hip and spine and serum biomarkers of bone formation (alkaline phosphase, AlkphaseB) and resorption (Serum N-terminal telopeptide, NTx). Our central hypothesis is that improvements in bone strength will be greater in subjects randomized to the Exercise group compared to subjects in either Control or Risedronate groups.DiscussionOur research aims to decrease the risk of osteoporotic fractures by improving bone strength in women with low bone mass (pre-osteoporotic) during their first 5 years’ post-menopause, a time of rapid and significant bone loss. Results of this study could be used in developing a clinical management pathway for women with low bone mass at their peak period of bone loss that would involve lifestyle modifications such as exercises prior to medications such as BPs.Trial registrationClinicaltrials.gov NCT02186600. Initial registration: 7/7/2014.
    34 schema:genre article
    35 schema:isAccessibleForFree true
    36 schema:isPartOf N16ed63de8291457e8a6e5d3cef33698c
    37 N17175eeb0ec944268462dccf5ec2c9d5
    38 sg:journal.1028438
    39 schema:keywords BackgroundIn
    40 CAD
    41 Secondary outcomes
    42 United States
    43 adverse effects
    44 biomarkers
    45 bisphosphonates
    46 bone formation
    47 bone loss
    48 bone mass
    49 bone mineral density
    50 bone strength
    51 bone structure
    52 bone turnover
    53 bone-loading exercises
    54 calcium
    55 central hypothesis
    56 changes
    57 clinical management pathway
    58 control
    59 density
    60 effect
    61 exercise
    62 exercise group
    63 exercise history
    64 exercise program
    65 formation
    66 fractures
    67 group
    68 hip
    69 history
    70 hypothesis
    71 improvement
    72 lifestyle modification
    73 long-term use
    74 loss
    75 low bone mass
    76 management pathway
    77 mass
    78 measures
    79 mechanical stress
    80 medications
    81 mineral density
    82 modification
    83 months
    84 months of treatment
    85 osteopenic postmenopausal women
    86 osteoporosis
    87 osteoporotic fractures
    88 outcomes
    89 pathway
    90 peak period
    91 period
    92 post-menopausal women
    93 postmenopausal women
    94 potential
    95 prevention
    96 prevention of osteoporosis
    97 primary outcome
    98 program
    99 protocol
    100 research
    101 resorption
    102 results
    103 risedronate
    104 risedronate group
    105 risk
    106 risk of osteoporosis
    107 samples
    108 serum biomarkers
    109 significant bone loss
    110 sites
    111 spine
    112 state
    113 strength
    114 stress
    115 structure
    116 structure measures
    117 study
    118 subjects
    119 time
    120 treatment
    121 treatment groups
    122 trials
    123 turnover
    124 use
    125 vitamin D
    126 women
    127 years
    128 schema:name Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women
    129 schema:pagination 59
    130 schema:productId N0c82a6d5d4854f8faa0d1de3d9c2a52c
    131 N0e9542a2f4254f1480f586931c31876d
    132 Nb6b972b74dd642a2b346e6e2e8a96203
    133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015577465
    134 https://doi.org/10.1186/s12905-016-0339-x
    135 schema:sdDatePublished 2022-11-24T21:00
    136 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    137 schema:sdPublisher N89897782629e4f258ab53e7cdd984d26
    138 schema:url https://doi.org/10.1186/s12905-016-0339-x
    139 sgo:license sg:explorer/license/
    140 sgo:sdDataset articles
    141 rdf:type schema:ScholarlyArticle
    142 N0c82a6d5d4854f8faa0d1de3d9c2a52c schema:name dimensions_id
    143 schema:value pub.1015577465
    144 rdf:type schema:PropertyValue
    145 N0e9542a2f4254f1480f586931c31876d schema:name doi
    146 schema:value 10.1186/s12905-016-0339-x
    147 rdf:type schema:PropertyValue
    148 N10ad433919b94c5c834d2ddca7fd041d rdf:first sg:person.0714345342.23
    149 rdf:rest N66a920ff9d6a4e4f9c9061393c0870ec
    150 N16ed63de8291457e8a6e5d3cef33698c schema:issueNumber 1
    151 rdf:type schema:PublicationIssue
    152 N17175eeb0ec944268462dccf5ec2c9d5 schema:volumeNumber 16
    153 rdf:type schema:PublicationVolume
    154 N248e4c11d6554fa49236aeefc4fe1e84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Humans
    156 rdf:type schema:DefinedTerm
    157 N2bbd40b607904e0497c1a735bb38cd16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Aged
    159 rdf:type schema:DefinedTerm
    160 N3867c77992f8403b8ac605b9e55ac20a rdf:first N61809699482a43cc8cf190ecd7c22a32
    161 rdf:rest Naca6a77176004eafa1f8e95da4a9867c
    162 N3875a5f56e5b428cabab07d100690e53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Biomarkers
    164 rdf:type schema:DefinedTerm
    165 N3977192510c044b1ae449bedc372e0ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Osteoporosis
    167 rdf:type schema:DefinedTerm
    168 N461720e267244889868f2074bf5b13e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Osteoporosis, Postmenopausal
    170 rdf:type schema:DefinedTerm
    171 N494f85b609334c88be43ae538f242f39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Female
    173 rdf:type schema:DefinedTerm
    174 N56cda81e8b3b42d2ac32ff072283b944 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Randomized Controlled Trials as Topic
    176 rdf:type schema:DefinedTerm
    177 N5a4fec79c38140a399eb67923fde508d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Bone Density Conservation Agents
    179 rdf:type schema:DefinedTerm
    180 N5d6ab7748f4f46f5b6e76105fced6b06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Osteoporotic Fractures
    182 rdf:type schema:DefinedTerm
    183 N61809699482a43cc8cf190ecd7c22a32 schema:affiliation grid-institutes:grid.429696.6
    184 schema:familyName Meisinger
    185 schema:givenName Melissa
    186 rdf:type schema:Person
    187 N64de312c6af94fbba9adf2a355c5e2cd rdf:first sg:person.012673232265.95
    188 rdf:rest Nf486df88fca94024b2a9c00463a3c631
    189 N66a920ff9d6a4e4f9c9061393c0870ec rdf:first sg:person.01210654346.14
    190 rdf:rest N64de312c6af94fbba9adf2a355c5e2cd
    191 N79f0fade436c4f11a5409a7bcfa20fe8 rdf:first sg:person.01332176174.10
    192 rdf:rest Nb7440692d13e4bcb89f937efda45879b
    193 N7d2bad81cd7c4c9e9419435f599a413d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Postmenopause
    195 rdf:type schema:DefinedTerm
    196 N82a7637152974d4ea9e6c756ee24de05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    197 schema:name Research Design
    198 rdf:type schema:DefinedTerm
    199 N89897782629e4f258ab53e7cdd984d26 schema:name Springer Nature - SN SciGraph project
    200 rdf:type schema:Organization
    201 N898f21f1dff54217b1ab17e714b95bb2 rdf:first sg:person.0765272574.62
    202 rdf:rest N10ad433919b94c5c834d2ddca7fd041d
    203 N8fca0d87e34b4c819f42b598bf3f3c48 rdf:first sg:person.0660737247.10
    204 rdf:rest N898f21f1dff54217b1ab17e714b95bb2
    205 Naca6a77176004eafa1f8e95da4a9867c rdf:first Nd29aa90337054f2f80ec78c23f6178ae
    206 rdf:rest Nc619f7e426ff4deb89abe885b70b9db1
    207 Nadf46bc09c1a49ae8771d6e1d4a2cabf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    208 schema:name Exercise
    209 rdf:type schema:DefinedTerm
    210 Nb5bc14b47e28450b95d8f338ef7b121e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    211 schema:name Middle Aged
    212 rdf:type schema:DefinedTerm
    213 Nb6b972b74dd642a2b346e6e2e8a96203 schema:name pubmed_id
    214 schema:value 27576310
    215 rdf:type schema:PropertyValue
    216 Nb7440692d13e4bcb89f937efda45879b rdf:first sg:person.015063553665.11
    217 rdf:rest N3867c77992f8403b8ac605b9e55ac20a
    218 Nc619f7e426ff4deb89abe885b70b9db1 rdf:first sg:person.07753443465.98
    219 rdf:rest rdf:nil
    220 Nd2508b96deea418a94ee930b1e4ffec0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    221 schema:name Aged, 80 and over
    222 rdf:type schema:DefinedTerm
    223 Nd29aa90337054f2f80ec78c23f6178ae schema:affiliation grid-institutes:grid.429696.6
    224 schema:familyName Portelli-Trinidad
    225 schema:givenName Ashlee
    226 rdf:type schema:Person
    227 Nf486df88fca94024b2a9c00463a3c631 rdf:first sg:person.0741432654.45
    228 rdf:rest N79f0fade436c4f11a5409a7bcfa20fe8
    229 Nff9ae797fa604c169e59904d506c7bd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    230 schema:name Risedronic Acid
    231 rdf:type schema:DefinedTerm
    232 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    233 schema:name Medical and Health Sciences
    234 rdf:type schema:DefinedTerm
    235 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    236 schema:name Clinical Sciences
    237 rdf:type schema:DefinedTerm
    238 sg:grant.3806235 http://pending.schema.org/fundedItem sg:pub.10.1186/s12905-016-0339-x
    239 rdf:type schema:MonetaryGrant
    240 sg:journal.1028438 schema:issn 1472-6874
    241 schema:name BMC Women's Health
    242 schema:publisher Springer Nature
    243 rdf:type schema:Periodical
    244 sg:person.01210654346.14 schema:affiliation grid-institutes:grid.266813.8
    245 schema:familyName Kupzyk
    246 schema:givenName Kevin A.
    247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210654346.14
    248 rdf:type schema:Person
    249 sg:person.012673232265.95 schema:affiliation grid-institutes:grid.429696.6
    250 schema:familyName Mack
    251 schema:givenName Lynn R.
    252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012673232265.95
    253 rdf:type schema:Person
    254 sg:person.01332176174.10 schema:affiliation grid-institutes:grid.266815.e
    255 schema:familyName Berg
    256 schema:givenName Kris
    257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332176174.10
    258 rdf:type schema:Person
    259 sg:person.015063553665.11 schema:affiliation grid-institutes:grid.429696.6
    260 schema:familyName Langel
    261 schema:givenName Meghan
    262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015063553665.11
    263 rdf:type schema:Person
    264 sg:person.0660737247.10 schema:affiliation grid-institutes:grid.429696.6
    265 schema:familyName Bilek
    266 schema:givenName Laura D.
    267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660737247.10
    268 rdf:type schema:Person
    269 sg:person.0714345342.23 schema:affiliation grid-institutes:None
    270 schema:familyName Lappe
    271 schema:givenName Joan M.
    272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714345342.23
    273 rdf:type schema:Person
    274 sg:person.0741432654.45 schema:affiliation grid-institutes:grid.254748.8
    275 schema:familyName Cullen
    276 schema:givenName Diane M.
    277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741432654.45
    278 rdf:type schema:Person
    279 sg:person.0765272574.62 schema:affiliation grid-institutes:grid.266813.8
    280 schema:familyName Waltman
    281 schema:givenName Nancy L.
    282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765272574.62
    283 rdf:type schema:Person
    284 sg:person.07753443465.98 schema:affiliation grid-institutes:grid.429696.6
    285 schema:familyName Lang
    286 schema:givenName Molly
    287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07753443465.98
    288 rdf:type schema:Person
    289 sg:pub.10.1007/s00198-009-1083-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1047106998
    290 https://doi.org/10.1007/s00198-009-1083-y
    291 rdf:type schema:CreativeWork
    292 sg:pub.10.1007/s00198-012-2224-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026832189
    293 https://doi.org/10.1007/s00198-012-2224-2
    294 rdf:type schema:CreativeWork
    295 sg:pub.10.1007/s00198-012-2240-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038429533
    296 https://doi.org/10.1007/s00198-012-2240-2
    297 rdf:type schema:CreativeWork
    298 sg:pub.10.1007/s00198-013-2424-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036817206
    299 https://doi.org/10.1007/s00198-013-2424-4
    300 rdf:type schema:CreativeWork
    301 sg:pub.10.1007/s00198-014-2794-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038754393
    302 https://doi.org/10.1007/s00198-014-2794-2
    303 rdf:type schema:CreativeWork
    304 sg:pub.10.1007/s00223-012-9668-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023163828
    305 https://doi.org/10.1007/s00223-012-9668-4
    306 rdf:type schema:CreativeWork
    307 sg:pub.10.1007/s00223-013-9763-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007894857
    308 https://doi.org/10.1007/s00223-013-9763-1
    309 rdf:type schema:CreativeWork
    310 sg:pub.10.1007/s00223-015-9980-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1020842897
    311 https://doi.org/10.1007/s00223-015-9980-x
    312 rdf:type schema:CreativeWork
    313 sg:pub.10.1007/s11914-007-0003-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005231316
    314 https://doi.org/10.1007/s11914-007-0003-3
    315 rdf:type schema:CreativeWork
    316 sg:pub.10.1186/2193-1801-2-331 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013150939
    317 https://doi.org/10.1186/2193-1801-2-331
    318 rdf:type schema:CreativeWork
    319 sg:pub.10.1207/s15327558ijbm1101_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064221287
    320 https://doi.org/10.1207/s15327558ijbm1101_2
    321 rdf:type schema:CreativeWork
    322 sg:pub.10.1385/1-59259-278-3:185 schema:sameAs https://app.dimensions.ai/details/publication/pub.1088540921
    323 https://doi.org/10.1385/1-59259-278-3:185
    324 rdf:type schema:CreativeWork
    325 grid-institutes:None schema:alternateName Creighton Osteoporosis Research Center, 601 North 30th, 68131, Omaha, NE, USA
    326 schema:name Creighton Osteoporosis Research Center, 601 North 30th, 68131, Omaha, NE, USA
    327 rdf:type schema:Organization
    328 grid-institutes:grid.254748.8 schema:alternateName Biomedical Science, Creighton University, 68102, Omaha, NE, USA
    329 schema:name Biomedical Science, Creighton University, 68102, Omaha, NE, USA
    330 rdf:type schema:Organization
    331 grid-institutes:grid.266813.8 schema:alternateName Center for Nursing Science, University of Nebraska Medical Center, 4101 Dewey Avenue, 68198-5330, Omaha, NE, USA
    332 College of Nursing, University of Nebraska Medical Center, 1230 O Street, Suite 131, 68588-0220, Lincoln, NE, USA
    333 schema:name Center for Nursing Science, University of Nebraska Medical Center, 4101 Dewey Avenue, 68198-5330, Omaha, NE, USA
    334 College of Nursing, University of Nebraska Medical Center, 1230 O Street, Suite 131, 68588-0220, Lincoln, NE, USA
    335 rdf:type schema:Organization
    336 grid-institutes:grid.266815.e schema:alternateName School of HPER, University of Nebraska at Omaha, 68162-0216, Omaha, NE, USA
    337 schema:name School of HPER, University of Nebraska at Omaha, 68162-0216, Omaha, NE, USA
    338 rdf:type schema:Organization
    339 grid-institutes:grid.429696.6 schema:alternateName College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA
    340 Diabetes, Endocrinology, & Metabolism, Nebraska Medicine, 68198-4130, Omaha, NE, USA
    341 Heartland Osteoporosis Research Study, College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA
    342 schema:name College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA
    343 Diabetes, Endocrinology, & Metabolism, Nebraska Medicine, 68198-4130, Omaha, NE, USA
    344 Heartland Osteoporosis Research Study, College of Allied Health Professions, 984000 Nebraska Medical Center, 68198-4000, Omaha, NE, USA
    345 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...